chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediate: high fever, lethergy, crankiness. Two days later: unable to stand for several hours. Within weeks: loss of balance, loss of ability to stand, loss of ability to walk, gross motor regression, inablity to hold head up, difficulty breathing.
Approximately 18 hours after the injection I developed a high fever (101.2)  along with a slight ache in the joints.  This continued approx. 18 hours and the fever decreased.   The fever is significant in that my normal body temperature is 96.4 so it was an increase of almost 5 degrees.  Currently I' m feeling fine .
Fever up to 101.8, chills, body aches and bilateral knee and ankle swelling intermittently for up to 1 month post vaccine.
heart was racing; like no sense of orientation or distance or depth; muscle pain; feels like I just ran a marathon; dizziness; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart was racing), DISORIENTATION (like no sense of orientation or distance or depth), MYALGIA (muscle pain), FEELING ABNORMAL (feels like I just ran a marathon) and DIZZINESS (dizziness) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004D21A and 054C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Jul-2021, the patient experienced PALPITATIONS (heart was racing), DISORIENTATION (like no sense of orientation or distance or depth), MYALGIA (muscle pain), FEELING ABNORMAL (feels like I just ran a marathon), DIZZINESS (dizziness) and FATIGUE (tiredness). At the time of the report, PALPITATIONS (heart was racing), DISORIENTATION (like no sense of orientation or distance or depth), MYALGIA (muscle pain), FEELING ABNORMAL (feels like I just ran a marathon), DIZZINESS (dizziness) and FATIGUE (tiredness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jul-2021, Heart rate decreased: (abnormal) unknown. On 12-Jul-2021, Heart rate increased: (abnormal) unknown.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Patient developed lip and mouth numbness and itchy throat within minutes of receiving Pfizer vaccine.  She was treated with Benadryl.  She was monitored for about 1.5 hours and symptoms gradually resolved.
This spontaneous report as received from a health professional refers to a 1-year-old patient (gender was not reported). There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 11-NOV-2015, the patient was vaccinated with an improperly stored dose of VARIVAX lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
One week after the injection, the site became very red, swollen, and itchy. They skin is also raised. It does not happen every day but it comes and goes
Discharge Provider: MD;* Primary Care Physician at Discharge: MD Admission Date: 1/22/2023   PRESENTING PROBLEM: Multifocal pneumonia [J18.9]   HOSPITAL COURSE: Patient is a 65 y.o. female with a history of mantle cell lymphoma, pulmonary emboli on Eliquis and GAD who presented with cough and shortness of breath. Patient stated she has not been feeling well since the beginning of the month. She stated she has fever, chills, cough, persistent diarrhea, decreased appetite and malaise. On 1/5/2023 she was diagnosed with COVID and treated with molnupiravir. She endorsed being incontinent due to perfuse diarrhea and had little oral intake. The diarrhea has resolved but she continues with a cough, increasing shortness of breath and fatigue. Her husband called 911 and EMS arrived. Patient was found to be hypoxic and placed on 4L 02 to maintain sats above 90%.   Upon arrival to the emergency department patient was found to be hypotensive and was given a 1 L bolus of IV fluids.  She was hypoxic and placed on 2 L of oxygen to maintain sats above 90%.  COVID PCR positive.  Lab work was relatively unremarkable.  Blood gas did demonstrate hypoxia.  Chest x-ray demonstrated extensive bilateral airspace opacities suspicious for multifocal pneumonia.  Blood cultures were drawn and she was given IV Rocephin, azithromycin and vancomycin.  She was admitted with hospitalist services for further care and treatment of COVID-19, multifocal pneumonia and hypoxia.   Patient was started on IV cefepime and vancomycin.  Patients diarrhea returned and then subsided without testing.  Blood cultures positive for Staph hominis.  Repeat blood cultures obtained.  ID consulted and suspected patient has bacterial super infection after COVID, ID recommendations were followed. She completed a 10 day course of antibiotics.   Her oxygen needs waxed and waned. She was diuresed with lasix. She had to be moved to ICU for hypotension and was given fluid boluses and intermittently levophed was used to maintain blood pressure. She slowly started to improve and oxygen demand was decreasing. Then February 3 and 4 her oxygen demand significantly increased requiring HFNC on the evening of 2/4. CTA indicated worsening Covid pneumonia and ruled out PE. Patient wishes were reviewed and she continued to be adamant about not wanting intubation.    VICU and ID were participating in care. She was again started on broad spectrum antibiotics. She had intermittent hypotension and maintaining peripheral access was difficult. A PICC line was placed, and supportive care with pressers continued. Due to worsening need for oxygen and hypotension goals of care were again discussed and Hospice was consulted for further assistance on February 6th. Patient and husband made plan to discharge home with hospice, but unfortunately after completion of plans and being left alone her oxygen needs increased and were being met by HFNC at 95% and a venti mask. She was made comfort measures on 2/6 in the evening and passed away at 7:03 on 2/7/23 with husband and granddaughter at bedside. Hospice was notified.
More than 35 days since first shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 35 days since first shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 35 days since first shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 35 days since first shot) had resolved.            No relevant concomitant medications were reported. Treatment information was unknown.
Pt recvd 1st dose of Hep B vax on 28JUN91 & exp numbness & tingling on rt side of face & rt arm w/assoc dizziness & vertigo; neuro ex, LLP, auditory evoked; MRI scan for multiple sclerosis were neg;
Information has been received from a physician concerning a female who on an unknown date was vaccinated with a dose of GARDASIL, 15 minutes after her shot, the patient passed out. At the time of this report, the outcome was unknown. Patient sought unspecified medical attention. Additional information has been requested.
Rash/Hives covering most of body. Admin 2/1/18, reported adverse RXN 2/9/18.
Rash on the arm that she got the shot in; Other arm is getting a rash as well; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on the arm that she got the shot in) and RASH (Other arm is getting a rash as well) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash on the arm that she got the shot in) and RASH (Other arm is getting a rash as well). At the time of the report, VACCINATION SITE RASH (Rash on the arm that she got the shot in) and RASH (Other arm is getting a rash as well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Feb-2021 and was forwarded to Moderna on 16-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on the arm that she got the shot in) and RASH (Other arm is getting a rash as well) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash on the arm that she got the shot in) and RASH (Other arm is getting a rash as well). At the time of the report, VACCINATION SITE RASH (Rash on the arm that she got the shot in) and RASH (Other arm is getting a rash as well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.
Started 3 days after receiving vaccination. Red dots on legs and arms. The dots doesn't itch or hurt.
Fever of 102.1 10/25/2009 Toward the end of that night he was acting alittle spacey.
After all 3 immunizations were administered, the child was crying inconsolably, gasping for air. Face and body turned purple and blue. Body went limp for a couple of seconds. Regained consciousness. We administer oxygen and alerted 911. Kept for observation in office.
This is an instance of COVID-19 breakthrough disease after which death occurred. The individual was vaccinated with the Pfizer product on 01/21/2021, 02/11/2021, 09/28/2021, and 04/30/2022. They presented to emergency department on 08/24/2022 and were discharged after evaluation but then presented again later the same day due to acute delirium. The individual was admitted to hospital. They were diagnosed with complications of acute hypoxic respiratory failure and acute respiratory distress syndrome. It is not well known if the individual experienced COVID-19 symptoms due to poor historian (dementia). They tested positive for COVID-19 on 08/24/2022. Their health continued to decline and they remained hospitalized until their death on 08/27/2022.
8FEB99 inc temp, congestion, cough, APAP, 02, ATB, (bactrim),flu dx;
GOT BOTH SHOT ONLY HAD A SLIGHT RASH ON ARM; GOT BOTH SHOT ONLY HAD / SORE AREM; This case was reported by a consumer via interactive digital media and described the occurrence of localized rash in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine, the patient experienced localized rash and pain in arm. On an unknown date, the outcome of the localized rash and pain in arm were recovered/resolved.   It was unknown if the reporter considered the localized rash and pain in arm to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by patient himself/herself. The age at vaccination was not reported. The age group was not reported but was selected as an adult as per vaccine indication. The patient received Shingles vaccine last year and had a slight rash on arm and sore arm, that went away, and the patient been fine. The follow-up would not possible as no contact details were available. For tolerance of 2nd dose refer case US2021AMR072688.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR072688:Same reporter.
Pt received Pfizer COVID vaccine, was walking with father next to her, felt faint, and father eased her to the floor, no head or body injury. Positive pallor and diaphoresis noted, legs elevated and pt color improved with pt now alert and oriented. Assisted to upright position, onto stretcher, given 1 small bottle water po, BP: 108/68, HR: 87, RR: 16 nonlabored, SaO2: 100% on RA. Pt currently has menses. 1023: drank 1 apple juice, feeling better. 1038: BP: 94/53, HR: 64, RR: 16 nonlabored, Sa02: 100% on RA. Sat upright on stretcher, legs dangling. 1044: BP 91/58, HR: 70, RR: 16 nonlabored, SaO2: 100% on RA, feeling well, drank 2 apple juice cups, standing up. 1049: standing up BP: 84/46, HR: 62, RR: 16 nonlabored, SaO2: 100% on RA. 1100: Pt feeling well, no c/o, escorted to front door of hospital, father at side. Pt aware to drink fluids today and especially during menses. Pt is also a dancer and practices every day. Discussed hydration needs prior to discharge from vaccine clinic. Pt aware to discuss vasovagal response from this injection at next visit so pt can lay down.
armpit swelling; Itchiness, injection site and armpit swelling/It started itching and it is a little swollen; It is like the injection site reaction; Redness and swelling around the injection site; Redness and swelling around the injection site; This is a spontaneous report from a contactable Nurse (patient) reported for herself. A 34-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot: EJ1685, expiry date: Mar2021) via an unspecified route of administration on 29Dec2020 at single dose for COVID-19 immunisation. Medical history included asthma, anxiety. Concomitant medication included salbutamol (ALBUTEROL) for asthma, venlafaxine hydrochloride (EFFEXOR) for anxiety. The patient had noticed redness and swelling around the injection site. It doesn't seem like an infection but a typical reaction. This happened to the patient on day 8 post vaccination (06Jan2021). She also reported itchiness, injection site and armpit swelling since last night (06Jan2021). She had her vaccine on 29Dec2020 and then the last night (06Jan2021) it started itching and it is a little swollen. It is like the injection site reaction but she did not know it was normal this far after getting it. Like she was just curious that sort of reaction is normal this far after getting the vaccine. Events outcome was unknown.
Fast heart rate; This is a spontaneous report received from a contactable consumer (Patient) via Pfizer sponsored program. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), Solution for injection, via an unspecified route of administration on 22Mar2021 as single dose for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. On an unspecified date in Mar2021, the patient experienced fast heart rate. She got her 1st dose of the vaccine on 22Mar2021. She called about the side effects of the vaccine. She said she experienced a fast heart rate after getting the 1st dose of the vaccine. The outcome of event was unknown.   Follow-up attempts completed. No further information expected.
Inconsolable, high pitched cry for >3 hrs; afebrile; no local rxn; vomiting;
The client presented to the clinic on 6/24/19 complaining of having a rash that developed after her travel consult appointment Thursday June 20, 2019. I brought the client back to a clinic room and she told me after receiving the Typhoid vaccine at our clinic, the client had a "headache, diarrhea, and arm pain."  The next day she said she developed a rash on her chest and neck. It is comprised of pimple-like, red, raised bumps that she says itch. It has spread up from her neck to her face since Friday. She also had an achy back pain that she rated was a 9 out of ten on a scale of one to ten. She said she still has the pain today and it is a 4 out of ten. She denies having chills,  and did not check her temperature for a fever. She took Ibuprofen as needed. She said it "kinda helped" the pain. She did not describe having any difficulty breathing or swelling of the face or throat. I did not see any redness or swelling at the injection site.
dizziness; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), NAUSEA (nausea) and VOMITING (vomiting) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088B21A) for COVID-19 vaccination.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and NORETHISTERONE (NORLYDA) for an unknown indication.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Aug-2021, the patient experienced DIZZINESS (dizziness), NAUSEA (nausea) and VOMITING (vomiting). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness), NAUSEA (nausea) and VOMITING (vomiting) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Macular papular rash started on knee X 3 1/2 weeks, then spread over entire body. Dx by dermatologist as a acral papular dermatitis (Gianatti Crosti). Tx with steroid cream and Zyrtec.
Headache, Myalgia, Fever, TIRED/CHILLS Narrative:
EXTREME PAIN IN RIGHT LEG; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported) dose was not reported, administered on 13-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 13-APR-2021, the subject experienced extreme pain in right leg. Laboratory data (dates unspecified) included: Diagnostic ultrasound (NR: not provided) Not reported. The action taken with covid-19 vaccine  was not applicable. The outcome of extreme pain in right leg was not reported. This report was non-serious.
This spontaneous report was received from a certified medical assistant (CMA) concerning an unspecified patient. It was reported that 1 improperly stored RECOMBIVAX HB (dose, route, lot# not reported) had been administered to the patient on unspecified date. No adverse effects were reported. No PQC was involved. This is one of several reports received from the same source. Additional information has been requested.
annular shaped erythimic  2inches in length, one inch other way, very pink with white centers  slightly raised      scattered about from knees to right below the breast, no itching, no drainage, they are just beginning to go away. some were larger than others  when one actually went away the skin broke, very dry as if you had a sunburn and it was peeling
Temporary loss of vision; unilateral leg swelling; This spontaneous case was reported by a physician and describes the occurrence of BLINDNESS TRANSIENT (Temporary loss of vision) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Knee replacement. Concurrent medical conditions included Blood pressure high since 2014 and Benign prostatic hypertrophy since 2000.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLINDNESS TRANSIENT (Temporary loss of vision) (seriousness criterion medically significant) and PERIPHERAL SWELLING (unilateral leg swelling). At the time of the report, BLINDNESS TRANSIENT (Temporary loss of vision) and PERIPHERAL SWELLING (unilateral leg swelling) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-235138, MOD-2021-040178 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Moderna COVID-19 Vaccine EUA I had swollen lymph nodes in my arm for the week after my vaccination. A week after my first dose (4/9/21) I started getting a rash at the injection site. It travelled around my arm from the spot where the needle injected me, towards the inside of my arm and down toward my elbow. I have been taking a typical antihistamine from drug store and applying hydrocortisone to the area. It provides a little relief but my arm is still swollen, hot, and itchy.
48 hours SID DPT & IPV at left thigh- pts has 5 inch X 2 1/2 inch reddened slightly swollen & somewhat painful area at thigh. Temperature 36.7 Given Keflex 250 mg QID for 10 days.
patient states she felt a burning sensation in the arm where the vaccine was injected then it spread to the other arm and down to her stomach. this effect lasted 5 hours. she did not take any medication
Jaw pain on right side, pain behind the ear. unable to eat. Unable to close mouth/jaw on right side. pain in the right side head and down the neck.
Seizure/status epilepticus. Received multiple medications and intubation; airlifted to regional hospital. Afebrile at presentation in ER.
I had left work feeling well. Nothing in my diet had changed.I went to get my first vaccine.I was offered moderna.The pharmacist asked my allergies.Wrote those down on a piece of paper.About 15 minutes after I had gotten my vaccine,I still felt fine.2 hours later I had gotten really tired.I figured it was a side effect from the shot.At about 3 a.m. ,I woke up extremely sick.I could not stop vomitting.This went on for about an hour.I drank some water and went back to bed.At about 8:00 a.m. I woke up again vomitting.I had to call to come to my house to help me.I had some ginger ale and saltine crackers by noon.I stopped vomitting by 4 p.m.(24 hrs later).I had this really weird taste/sensation in my mouth.I told about this metal taste in my mouth.This continued for 5 days until I went to urgent care.